ISER 2020

C1106 BKG Buenos Aires, Argentinien

ISER 2020

25th Biennial Meeting of the International Society for EYE Research

Datum:
25.10.2020, 08:00 - 29.10.2020
Veranstalter:
International Society for Eye Research (ISER)
Kurzbeschreibung:
The ISER 2020 will be held in Buenos Aires, Argentina. At the congress, leading clinicians and vision researchers will share their latest findings, technical expertise and experiences in their field, at both clinical and laboratory levels. Symposia address topics with broad, interdisciplinary interest and are balanced with plenary lectures and poster sessions.
Fortbildungspunkte: 

alle

Max. Teilnehmer: unbegrenzt
Gebühren ab: 715,00 EUR
EarlyBird bis 07.07.2020:

Hinweis:
Early Registration: until 7 July 2020
ISER Member $480,00
Non-Member $715,00
Young Investigator $350,00
Young Investigator Non-member $530,00
Student $300,00

Students require a signed letter from a mentor.


Standard Registration: 8 July – 15 September 2020
ISER Member $550,00
Non-Member $765,00
Young Investigator $350,00
Young Investigator Non-member $530,00
Student $380,00

Late/Onsite Registration: Starting 16 September 2020
ISER Member $640,00
Non-Member $850,00
Young Investigator $350,00
Young Investigator Non-member $530,00
Student $420,00


Others
Single day* only ISER Member and Non-member $200,00
Single day* only YI Member and Non-member, Student $160,00
Single day* only Sunday Opening $80,00
Accompanying Person $160,00
Exhibitor (additional) $50,00

für Referenten

Abstract: 15.06.2020
Hinweis:
• Abstracts may be submitted for oral or poster presentation. The choice of format will be made
by the scientific program committee. Notification of format will be provided to the presenter
when the program has been finalized.
• Young Investigators* may submit abstracts for oral or poster presentation.
• Each participant is allowed to present only ONE abstract but can be listed as co-authors
on multiple abstracts.
• Tables must be saved and uploaded as JPEG files. Other file types (e.g. images) cannot be
accepted. Please note that these may be resized to fit in the final printed material.
• Abstracts submitted via fax will not be accepted.
• Submission of an abstract acknowledges your acceptance for the abstract to be published in
the official Meeting publications.
• Abstracts must be submitted before June 15, 2020 (Abstract Submission Deadline)
• Presenting authors of abstracts must be registered participants.
• Invited speakers must NOT submit their abstract(s) via the regular abstract submission
system. A link to another system has been sent to them.
• Abstracts must be original and must not be or have been published or presented at any other
meeting prior to the ISER Meeting.
• Abstracts must be submitted in English.
• Abstracts must be received by the announced deadline. Abstracts received after the deadline
will not be considered.
• The presenting author is required to ensure that all co-authors are aware of the content of the
abstract before submission to the Secretariat.
Bemerkungen:
Diese Veranstaltung findet 2-jährlich statt und bietet Fortbildungsmöglichkeiten für alle.
Veranstaltungsnummer: 31322
Gebühren ab: ab 715,00
verfügbare Plätze: unbegrenzt
Sprache: Englisch
 
Abstract: 15.06.2020
Anmeldeschluss: 01.01.1970
Vom Veranstalter gemeldetes Programm:
  Monday, 26 October 2020
  Buen Ayre B/C Buen Ayre A Quebracho A Quebracho B Pacará A          
8:00-10:00

GLA1

Molecular Pathways Involved in Outflow Changes in Glaucoma I

RPE1

Bestrophin-1

and Bestro-phinopathies

COS1

Ocular Surface Diseases

IMM1

Failure of the Ocular Immune Privilege

OPT1

New Therapeutic Directions for Ocular Tumors

         
 

Pacará B

Alerce

Sauce

Lenga

Jacarandá

         
 

OPT9

Optic Neuropathies and Optic Neuritis - New Concepts for Therapeutic and Treatment Delivery

 

LEN1

Systems Level Approaches to Lens Development and Pathology

 

RCB1

Cell Biology and Biophysics of Photoreceptors

 

RND1

Early Retinal Development and Patterning

 

RND4

Retinal Ganglion Cells and Optic Nerv

         
10:00- 13:00  Break
 

Buen Ayre B/C

Buen Ayre A

Quebracho A

Quebracho B

Pacará A

         
13:00- 15:00

GLA2

Molecular Pathways Involved in Outflow Changes in Glaucoma II

RPE2

Ionic Mechanisms at the RPE

COS2

New Approaches in the Diagnosis of Ocular Illnesses

IMM2

The Expanding Role of Inflammasome in Ocular Disease

OPT2

Diabetic Retinopathy: What’s New

 

 

 

 

 

 

 

 

 

 

 

Pacará B

Alerce

Sauce

Lenga

Jacarandá

         
 

OPT15

Diabetic Retinopathy - Inflammation and Beyond

 

LEN2

Lens Fibrosis and EMT

 

RCB2

Animal Models for Retinal Regeneration

 

RCB2

Animal Models for Retinal Regeneration

 

OGG3

Anterior Eye Gene Therapy

         
15:00- 15:30  Break
  Buen Ayre B/C Buen Ayre A Quebracho A Quebracho B Pacará A          
15:30- 17:30 GLA3

Anterior Segment Development, Segmental Flow and Stem Cells

RPE3

Strategies to Counter Retinal Dysfunction

 

COS3

New Approaches in Treatment of Corneal Illnesses I

IMM3

Aging and the Immune System

OPT10

Crystallins in Eye Disease

   

 

   

 

  Pacará B Alerce Sauce Lenga Jacarandá          
 

RCB3

Lipids in the Retina: The Good, the Bad, and the Ugly

LEN3

Therapeutic Strategies for Lens Disorders

RCB4

Focus on Cilia

RND2

Control of Retinal Cell Fate

OGG1

From Genotype-Phenotype Correlations to Disease Modelling in Retinal Disorders

         
  Tuesday, 27 October 2020 
  Buen Ayre B/C Buen Ayre A  Quebracho A Quebracho B  Pacará A  Pacará B  Alerce  Sauce  Lenga  Jacarandá 
08:00-10:00

iPSC2

Stem Cell-Based Paradigms for Ocular Drug Discovery

IMA2

Image Processing and Analysis

OPT6

Autophagy in Homeostasis and Survival of Ocular Tissues

RCB5

Lipids in Diabetic Retinopathies

GLA4

IOP, ICP and Retinal Vessel Wall and Pulse Wave Properties and ONH Imaging

COS4

The Biological Aspects of Human Corneal Endothelial Cells in Health and Disease

IMM4

Microglia

OGG2

Global Eye Genetics Consortium - Genetics Studies in South America

OPT7

Lipids and Lipid Signalling in Eye Diseases

EED2

Artificial Intelligence in Ocular Epidemiologic Research

10:00- 13:00  Break          
13:00-15:00  

iPSC3

iPSC-Organoid Based Disease Modeling

 

LEN5

Lens Biomechanics and Cytoskeleton

OPT8

Pharmacological Strategies for the Prevention of Retinopathy of Prematurity (ROP)

 
 

RCB6

Retinal

Energetics/

Metabolomics: Systemic Effects on Local Environments

 

GLA5

Beyond the Soma: Protecting Axons and Dendrites in Optic Neuropathy

 

IMM7

Parainflammation, Chronic Inflammation and Retinal Diseases

 

IMM5

Inflammation Associated with Contact Lenses

RND5

Retinal Regeneration and Cell-Based Therapies

RPE4

Therapeutic Approaches to Enhance Degradative and Oxidative Capacity of the RPE

 

OGG4

Non-coding RNA and Function in Eye Disease

15:00-15:30  Break          
15:30-17:30  

RCB7

Regulation of Müller Glia-Dependent Neuronal Regeneration in the Damaged Retina

 

OGG5

Gene Therapy in Retinal Diseases

 

OPT4

Novel Therapeutic Approaches for Retinopathies

 

RPE6

Lysosome Physiology

 

RND10

Non-coding RNAs in Retinal Health and Disease

 

EED3

Accomplishments, Current Status, and Future Challenges in Infectious Eye Disease

 

IMM6

Interaction of Systemic and Local Immune Cells in AMD Pathogenesis

 

RND6

Retinal Clocks and Non-Visual Opsins

 

RPE5

Epigenetics in the Posterior Eye

 

LEN4

Oxygen and Redox Control of Lens Differentiation, Homeostasis and Transparency

  Wednesday, 28 October 2020
  Buen Ayre B/C Buen Ayre A  Quebracho A Quebracho B  Pacará A  Pacará B  Alerce  Sauce Lenga Jacarandá 
08:00-10:00

OGG6

miRNAs in the Eye: From Development to Ocular Diseases

EED1

Myopia Update: What Causes School Myopia, and What Currently is the Best Therapy?

COS5

Nerves: From Passive Sensory Perception to Master Inflammatory Regulators in the Ocular Surface

GLA6

Glaucoma

Potpourr

LEN6

Eye Evolution

iPSC4

iPSC-RPE Based Disease Modeling

LEN7

Fiber Cell Membrane Organization and Lens Function

RPE7

Neurovascular Coupling in the Retina

OGG7

Ocular GWAS

RND8

Small Molecule Effectors in Retina Development, Function and Disease

10:00- 13:00  Break
13:00-15:00

IMM9

Systemic and Regional Immune Responses in Diabetic Retinopathy

IMA1

Molecular Imaging of the Retina

COS6

Regenerative Corneal Healing

GLA7

RGC Neuroprotection and Regeneration

LEN8

Signal Transduction in Normal Lens Development and Pathogenesis

OPT3

Glaucoma Gene Therapy

OPT11

Precision Medicine for Retinal Degeneration

RCB8

The Retinal Circadian Clock in Health and Disease

RCB9

Mitochondrial Dysfunction in Retinal Degeneration

RND9

Primary Cilia in Eye Development and Disease

15:00-15:30  Break
15:30-17:30

IMM8

Microbiome in Ocular Disease

iPSC1

Stem Cell-Derived Organoids and Eye Development

COS7

The Role of Viruses in Eye Diseases

COS8

Corneal Neighbors, Conjunctiva, Meibomian and Lacrimal Glands

GLA8

Understanding Exfoliation Glaucoma as a Multifactorial Disease

OPT12

Ocular Drug Delivery - Successes and Failures

GLA9

A Look at Glaucoma in the Year 2045. How Glaucoma Comprehension, Prevention, Treatments and Cures Might Look in 25 Years

RCB10

Glial Cell Involvement in Retinal Diseases

RCB11

Ocular Pigmentation and Vision

OPT13

Glaucoma Treatment –Paradigm Shift from Lowering IOP to Neuroprotection Needed?

  Thursday, 29 October 2020
 

Buen Ayre B/C

Quebracho A

Quebracho B

Pacará A

Pacará B

Alerce

Sauce

Lenga

Jacarandá  
08:00-10:00

IMM10

Retina Innate Immunity and its Role in Ocular Physiology and Disease

COS9

Corneal Stem Cells in Normal and Disease Conditions

GLA10

Mitochondria and Glaucoma

GLA11

Glaucoma Diagnostics and Biomarkers

OPT14

Retinopathy of Prematurity: Outer Retinal Dysfunction and Progressive Retinopathy

LEN9

Eye and Lens Regeneration

RCB12

Stress Signaling Pathways and Diabetic Retinopathy

RCB13

Balancing Retinal Degeneration with Regeneration: The Role of Microglia

iPSC5

Tissue Engineering and Microfluidic Approaches Using Ipsc Derived Ocular Cell Types

 
10:00- 13:00  Break
13:00-15:00

IMM11

Immunology in Glaucoma

COS10

Corneal Immunology in Norm and Disease

RPE8

RPE Homeostasis: Exploring Unbeaten Pathways and Novel Links

EED4

Telemedicine/Novel Technologies and Improving Eye Healthcare Delivery in a Global Setting

OPT5

Targeting and Treating Ocular Diseases Through Regulation of Stress Responses and Chaperone Pathways

LEN10

Channels, Water Homeostasis and Regulation of Lens Volume

RCB14

Neuronal Fate Determination in the Retina

 

IMA3

Recent Advances in Experimental Ophthalmoscopy

 
15:00-15:30  Break
15:30-17:30

GLA12

Glaucoma New Drug and New Treatment Development: Challenges, Opportunities and How to

COS11

Corneal Microbiome and Infections

RPE9

Interorganelle Communications during Aging and Pathological Processes in the Outer Retina

RND7

Retinal Degeneration and Remodeling

RND11

Mononuclear Phagocytes and Photoreceptors in Health and Disease

LEN11

Early Lens Development

RCB15

Thyroid Hormone in Cone Differentiation and Dysfunction

RPE10

Metabolism in the RPE

iPSC6

Cell-Based Regenerative Strategies for the Outer Retina Joint Minisymposium (RC And iPSC Sections)

 
 
Veranstaltungsort:
Hilton Buenos Aires
Anschrift:
Av, Macacha Güemes 351
C1106 BKG Buenos Aires, Argentinien
Veranstalter:
International Society for Eye Research (ISER)

Anmeldeschluss

Anmeldeschluss: 01.01.1970
Hinweis:
Scholarship application deadline June 15

Deadline for early registration fee July 7

Standard registration fee applies July 8

Deadline for standard registration fee Sep 15

Late registration fee applies Sep 16
Organisation:

ISER 2020
c/o K.I.T. Group
Kurfürstendamm 71
10709 Berlin
Germany

 
Hinweis:

 

Unfortunately, you cannot book this event event on Eyefox yet. You should ask the organizer to be able to book quickly and easily on Eyefox.

Do you know already? If you tick this event at My Events in your Member Area, you will be informed immediately when news become available!

 

 

You are the organizer?

Would you like to link your online registration here?

 

Download the order form here and send it back to us via fax or email.